Ape1 regulates WNT/β-catenin signaling through its redox functional domain in pancreatic cancer cells

  • Authors:
    • Shaojie Jiang
    • Lina Zhu
    • Haimei Tang
    • Miaofeng Zhang
    • Zhihua Chen
    • Jian Fei
    • Baosan Han
    • Gang-Ming Zou
  • View Affiliations

  • Published online on: June 12, 2015     https://doi.org/10.3892/ijo.2015.3048
  • Pages: 610-620
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

Apurinic/apyrimidinic endonuclease 1/redox factor-1 (Ape1/Ref-1, Ape1) is a multifunctional protein that is upregulated in human pancreatic cancer. Ape1 redox domain plays an essential role in regulating the effects of reactive oxygen species (ROS) generated during physiological metabolism and pathological stress. In the present study, we explored whether Ape1 and ROS affect WNT/β-catenin signaling. We used E3330, a small molecule inhibitor of the redox activity of Ape1, and a siRNA approach to knock down Ape1, in two human pancreatic cancer cell lines. Inhibition of Ape1 resulted in growth suppression of pancreatic cancer cells, increased ROS levels, upregulation of β-catenin and c-myc and downregulation of cyclin D1. Consistent with these data, overexpression of Ape1 in pancreatic cancer cells reduced ROS and c-myc levels and increased cyclin D1 levels. Moreover, treatment of pancreatic cancer cells with H2O2 to induce oxidative stress resulted in upregulated ROS levels, decreased Ape1 at both the mRNA and protein level, and alterations in WNT/β-catenin pathway components. Finally, treatment of pancreatic cancer cells with the WNT/β-catenin inhibitor IWR-1 resulted in growth inhibition, which was greatly enhanced when combined with E3330 treatment. In summary, our results demonstrate that ROS is an important intracellular messenger that can modulate WNT/β‑catenin signaling. The present study provides interesting new insight into crosstalk between the redox function of Ape1 and WNT/β-catenin signaling in cancer cells. Furthermore, our data show that the combination of Ape1 and WNT inhibitors enhanced the inhibition of pancreatic cell proliferation. These results provide a promising novel therapeutic strategy for treating pancreatic cancer in future.
View Figures
View References

Related Articles

Journal Cover

August-2015
Volume 47 Issue 2

Print ISSN: 1019-6439
Online ISSN:1791-2423

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
Jiang S, Zhu L, Tang H, Zhang M, Chen Z, Fei J, Han B and Zou G: Ape1 regulates WNT/β-catenin signaling through its redox functional domain in pancreatic cancer cells. Int J Oncol 47: 610-620, 2015.
APA
Jiang, S., Zhu, L., Tang, H., Zhang, M., Chen, Z., Fei, J. ... Zou, G. (2015). Ape1 regulates WNT/β-catenin signaling through its redox functional domain in pancreatic cancer cells. International Journal of Oncology, 47, 610-620. https://doi.org/10.3892/ijo.2015.3048
MLA
Jiang, S., Zhu, L., Tang, H., Zhang, M., Chen, Z., Fei, J., Han, B., Zou, G."Ape1 regulates WNT/β-catenin signaling through its redox functional domain in pancreatic cancer cells". International Journal of Oncology 47.2 (2015): 610-620.
Chicago
Jiang, S., Zhu, L., Tang, H., Zhang, M., Chen, Z., Fei, J., Han, B., Zou, G."Ape1 regulates WNT/β-catenin signaling through its redox functional domain in pancreatic cancer cells". International Journal of Oncology 47, no. 2 (2015): 610-620. https://doi.org/10.3892/ijo.2015.3048